Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.

Piechocka IK, Kurniawan NA, Grimbergen J, Koopman J, Koenderink GH.

J Thromb Haemost. 2017 May;15(5):938-949. doi: 10.1111/jth.13650. Epub 2017 Mar 6.

2.

Fibrinogen reduction and coagulation in cardiac surgery: an investigational study.

Gielen CL, Grimbergen J, Klautz RJ, Koopman J, Quax PH.

Blood Coagul Fibrinolysis. 2015 Sep;26(6):613-20. doi: 10.1097/MBC.0000000000000307.

PMID:
26083991
3.

Factor XIII stiffens fibrin clots by causing fiber compaction.

Kurniawan NA, Grimbergen J, Koopman J, Koenderink GH.

J Thromb Haemost. 2014 Oct;12(10):1687-96. doi: 10.1111/jth.12705. Epub 2014 Sep 18.

4.

Hydrodynamic characterization of recombinant human fibrinogen species.

Raynal B, Cardinali B, Grimbergen J, Profumo A, Lord ST, England P, Rocco M.

Thromb Res. 2013 Jul;132(1):e48-53. doi: 10.1016/j.thromres.2013.04.005. Epub 2013 Apr 30.

5.

Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.

Losekoot M, Ruivenkamp CA, Tholens AP, Grimbergen JE, Vijfhuizen L, Vermeer S, Dijkman HB, Cornelissen EA, Bongers EM, Peters DJ.

J Med Genet. 2012 Jan;49(1):37-40. doi: 10.1136/jmedgenet-2011-100452. Epub 2011 Nov 23.

PMID:
22114106
6.

A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.

Eefting D, Seghers L, Grimbergen JM, de Vries MR, de Boer HC, Lardenoye JW, Jukema JW, van Bockel JH, Quax PH.

Cardiovasc Res. 2010 Nov 1;88(2):367-75. doi: 10.1093/cvr/cvq203. Epub 2010 Jun 17.

PMID:
20562095
7.
8.

Prolonged in vivo gene silencing by electroporation-mediated plasmid delivery of small interfering RNA.

Eefting D, Grimbergen JM, de Vries MR, van Weel V, Kaijzel EL, Que I, Moon RT, Löwik CW, van Bockel JH, Quax PH.

Hum Gene Ther. 2007 Sep;18(9):861-9.

PMID:
17850190
9.

Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Schepers A, de Vries MR, van Leuven CJ, Grimbergen JM, Holers VM, Daha MR, van Bockel JH, Quax PH.

Circulation. 2006 Dec 19;114(25):2831-8. Epub 2006 Dec 4.

PMID:
17145993
10.

The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice.

Eefting D, Schepers A, De Vries MR, Pires NM, Grimbergen JM, Lagerweij T, Nagelkerken LM, Monraats PS, Jukema JW, van Bockel JH, Quax PH.

Atherosclerosis. 2007 Aug;193(2):335-42. Epub 2006 Nov 7.

PMID:
17087966
11.

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.

Lemckert AA, Grimbergen J, Smits S, Hartkoorn E, Holterman L, Berkhout B, Barouch DH, Vogels R, Quax P, Goudsmit J, Havenga MJ.

J Gen Virol. 2006 Oct;87(Pt 10):2891-9.

PMID:
16963747
12.

Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.

Schepers A, Eefting D, Bonta PI, Grimbergen JM, de Vries MR, van Weel V, de Vries CJ, Egashira K, van Bockel JH, Quax PH.

Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2063-9. Epub 2006 Jul 6.

PMID:
16825596
13.

Involvement of furin-like proprotein convertases in the arterial response to injury.

Sluijter JP, Verloop RE, Pulskens WP, Velema E, Grimbergen JM, Quax PH, Goumans MJ, Pasterkamp G, de Kleijn DP.

Cardiovasc Res. 2005 Oct 1;68(1):136-43.

PMID:
15963479
14.

Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Holterman L, Vogels R, van der Vlugt R, Sieuwerts M, Grimbergen J, Kaspers J, Geelen E, van der Helm E, Lemckert A, Gillissen G, Verhaagh S, Custers J, Zuijdgeest D, Berkhout B, Bakker M, Quax P, Goudsmit J, Havenga M.

J Virol. 2004 Dec;78(23):13207-15.

15.

Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP.

Plaisier M, Kapiteijn K, Koolwijk P, Fijten C, Hanemaaijer R, Grimbergen JM, Mulder-Stapel A, Quax PH, Helmerhorst FM, van Hinsbergh VW.

J Clin Endocrinol Metab. 2004 Nov;89(11):5828-36.

PMID:
15531549
16.

Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo.

van Weel V, Deckers MM, Grimbergen JM, van Leuven KJ, Lardenoye JH, Schlingemann RO, van Nieuw Amerongen GP, van Bockel JH, van Hinsbergh VW, Quax PH.

Circ Res. 2004 Jul 9;95(1):58-66. Epub 2004 May 20.

PMID:
15155530
17.

Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease.

Lamfers ML, Aalders MC, Grimbergen JM, de Vries MR, Kockx MM, van Hinsbergh VW, Quax PH.

Vascul Pharmacol. 2002 Dec;39(6):293-301.

PMID:
14567067
18.

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.

Vogels R, Zuijdgeest D, van Rijnsoever R, Hartkoorn E, Damen I, de Béthune MP, Kostense S, Penders G, Helmus N, Koudstaal W, Cecchini M, Wetterwald A, Sprangers M, Lemckert A, Ophorst O, Koel B, van Meerendonk M, Quax P, Panitti L, Grimbergen J, Bout A, Goudsmit J, Havenga M.

J Virol. 2003 Aug;77(15):8263-71.

19.

TR3 orphan receptor is expressed in vascular endothelial cells and mediates cell cycle arrest.

Arkenbout EK, van Bragt M, Eldering E, van Bree C, Grimbergen JM, Quax PH, Pannekoek H, de Vries CJ.

Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1535-40. Epub 2003 Jul 3.

PMID:
12842839
20.

Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.

van der Laan WH, Quax PH, Seemayer CA, Huisman LG, Pieterman EJ, Grimbergen JM, Verheijen JH, Breedveld FC, Gay RE, Gay S, Huizinga TW, Pap T.

Gene Ther. 2003 Feb;10(3):234-42.

PMID:
12571631
21.

Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency.

Bovenschen N, Herz J, Grimbergen JM, Lenting PJ, Havekes LM, Mertens K, van Vlijmen BJ.

Blood. 2003 May 15;101(10):3933-9. Epub 2003 Jan 9.

22.

Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.

Lamfers ML, Grimbergen JM, Aalders MC, Havenga MJ, de Vries MR, Huisman LG, van Hinsbergh VW, Quax PH.

Circ Res. 2002 Nov 15;91(10):945-52.

PMID:
12433840
23.

Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.

Collen A, Hanemaaijer R, Lupu F, Quax PH, van Lent N, Grimbergen J, Peters E, Koolwijk P, van Hinsbergh VW.

Blood. 2003 Mar 1;101(5):1810-7. Epub 2002 Sep 19.

24.

Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice.

Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B, Pannekoek H, de Vries CJ.

Circulation. 2002 Sep 17;106(12):1530-5.

PMID:
12234960
25.

Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice.

Lardenoye JH, De Vries MR, Grimbergen JM, Havekes LM, Knaapen MW, Kockx MM, van Hinsbergh VW, van Bockel JH, Quax PH.

Arterioscler Thromb Vasc Biol. 2002 Sep 1;22(9):1433-8.

PMID:
12231562
26.

Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype.

Engelse MA, Lardenoye JH, Neele JM, Grimbergen JM, De Vries MR, Lamfers ML, Pannekoek H, Quax PH, De Vries CJ.

Circ Res. 2002 May 31;90(10):1128-34.

PMID:
12039804
27.

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

Havenga MJ, Lemckert AA, Ophorst OJ, van Meijer M, Germeraad WT, Grimbergen J, van Den Doel MA, Vogels R, van Deutekom J, Janson AA, de Bruijn JD, Uytdehaag F, Quax PH, Logtenberg T, Mehtali M, Bout A.

J Virol. 2002 May;76(9):4612-20.

28.

Adenovirus-mediated transfer of the 39 kD receptor-associated protein increases fibrinolytic capacity.

Goedde MF, Grimbergen JM, Toet KH, Sitter T, Quax PH, Kooistra T.

Kidney Int. 2001 Jul;60(1):117-25.

29.

In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.

Lamfers ML, Lardenoye JH, de Vries MR, Aalders MC, Engelse MA, Grimbergen JM, van Hinsbergh VW, Quax PH.

Gene Ther. 2001 Apr;8(7):534-41.

30.

Improved adenovirus vectors for infection of cardiovascular tissues.

Havenga MJ, Lemckert AA, Grimbergen JM, Vogels R, Huisman LG, Valerio D, Bout A, Quax PH.

J Virol. 2001 Apr;75(7):3335-42. Erratum in: J Virol 2001 Jun;75(11):5440.

31.

Simultaneous detection of NOS-3 protein expression and nitric oxide production using a flow cytometer.

Havenga MJ, van Dam B, Groot BS, Grimbergen JM, Valerio D, Bout A, Quax PH.

Anal Biochem. 2001 Mar;290(2):283-91.

PMID:
11237331
32.

Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aalpha-chain, alters endothelial capillary tube formation.

Collen A, Maas A, Kooistra T, Lupu F, Grimbergen J, Haas FJ, Biesma DH, Koolwijk P, Koopman J, van Hinsbergh VW.

Blood. 2001 Feb 15;97(4):973-80.

33.

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

Quax PH, Lamfers ML, Lardenoye JH, Grimbergen JM, de Vries MR, Slomp J, de Ruiter MC, Kockx MM, Verheijen JH, van Hinsbergh VW.

Circulation. 2001 Jan 30;103(4):562-9.

PMID:
11157723
34.

Telemetric monitoring of blood pressure in freely moving mice: a preliminary study.

Kramer K, Voss HP, Grimbergen JA, Mills PA, Huetteman D, Zwiers L, Brockway B.

Lab Anim. 2000 Jul;34(3):272-80.

PMID:
11037121
35.

Adenoviral gene transfer of a u-PA receptor-binding plasmin inhibitor and green fluorescent protein: inhibition of migration and visualization of expression.

Lamfers ML, Wijnberg MJ, Grimbergen JM, Huisman LG, Aalders MC, Cohen FN, Verheijen JH, van Hinsbergh VW, Quax PH.

Thromb Haemost. 2000 Sep;84(3):460-7.

PMID:
11019972
36.

The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.

Braat EA, Collen A, Jie AF, Grimbergen JM, Rijken DC.

Biochim Biophys Acta. 2000 Sep 20;1497(3):351-8.

37.

Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.

Marchi R, Lundberg U, Grimbergen J, Koopman J, Torres A, de Bosch NB, Haverkate F, Arocha Piñango CL.

Thromb Haemost. 2000 Aug;84(2):263-70.

PMID:
10959699
38.

Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.

van der Laan WH, Pap T, Ronday HK, Grimbergen JM, Huisman LG, TeKoppele JM, Breedveld FC, Gay RE, Gay S, Huizinga TW, Verheijen JH, Quax PH.

Arthritis Rheum. 2000 Aug;43(8):1710-8.

39.

Calpainopathy-a survey of mutations and polymorphisms.

Richard I, Roudaut C, Saenz A, Pogue R, Grimbergen JE, Anderson LV, Beley C, Cobo AM, de Diego C, Eymard B, Gallano P, Ginjaar HB, Lasa A, Pollitt C, Topaloglu H, Urtizberea JA, de Visser M, van der Kooi A, Bushby K, Bakker E, Lopez de Munain A, Fardeau M, Beckmann JS.

Am J Hum Genet. 1999 Jun;64(6):1524-40.

40.

On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells.

Arts J, Grimbergen J, Toet K, Kooistra T.

Arterioscler Thromb Vasc Biol. 1999 Jan;19(1):39-46.

PMID:
9888864
41.

Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.

van Acker SA, Boven E, Kuiper K, van den Berg DJ, Grimbergen JA, Kramer K, Bast A, van der Vijgh WJ.

Clin Cancer Res. 1997 Oct;3(10):1747-54.

42.

Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.

Quax PH, Grimbergen JM, Lansink M, Bakker AH, Blatter MC, Belin D, van Hinsbergh VW, Verheijen JH.

Arterioscler Thromb Vasc Biol. 1998 May;18(5):693-701.

PMID:
9598826
43.

Oral endotrachael intubation of guineapigs.

Kramer K, Grimbergen JA, van Iperen DJ, van Altena K, Voss HP, Bast A.

Lab Anim. 1998 Apr;32(2):162-4.

PMID:
9587898
44.
45.

Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells.

Danen-Van Oorschot AA, Fischer DF, Grimbergen JM, Klein B, Zhuang S, Falkenburg JH, Backendorf C, Quax PH, Van der Eb AJ, Noteborn MH.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5843-7.

46.

The mechanism of red cell (dis)aggregation investigated by means of direct cell manipulation using multiple optical trapping.

Bronkhorst PJ, Grimbergen J, Brakenhoff GJ, Heethaar RM, Sixma JJ.

Br J Haematol. 1997 Feb;96(2):256-8.

PMID:
9029009
48.

Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectors.

van Acker SA, Kramer K, Voest EE, Grimbergen JA, Zhang J, van der Vijgh WJ, Bast A.

Cancer Chemother Pharmacol. 1996;38(1):95-101.

PMID:
8603459
49.

A new method to study shape recovery of red blood cells using multiple optical trapping.

Bronkhorst PJ, Streekstra GJ, Grimbergen J, Nijhof EJ, Sixma JJ, Brakenhoff GJ.

Biophys J. 1995 Nov;69(5):1666-73.

50.

Effect of dimethyl sulfoxide (DMSO) on the electrocardiogram (ECG) in freely moving male Balb/c mice.

Kramer K, Van Acker SA, Grimbergen JA, van den Berg DJ, Van der Vijgh WJ, Bast A.

Gen Pharmacol. 1995 Oct;26(6):1403-7.

PMID:
7590138

Supplemental Content

Loading ...
Support Center